Back to results
CompletedPhase 2

A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer

NCT00050427

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer — TrialFind